Highlights 2006/2007
Start Film
Video
Schering acquisition
crowns a strong year
We look back with satisfaction on an eventful and successful 2006 – a landmark year for Bayer, both strategically and operationally. Our employees around the world have good reason to be proud of last year’s accomplishment.
Phase III study for rivaroxaban under way Phase III study for
rivaroxaban under way
Based on positive research findings so far, a phase III study program for rivaroxaban was launched at the end of 2006. » more
 
Sector?s largest R&D budget Sector’s largest
R&D budget
The Bayer Group aims to further strengthen innovation as one of the most important goals of its corporate strategy. » more
 
Awards Awards
The German Environmental Reporting Award 2006 was presented to Bayer AG in 2006 for the country’s best Sustainable Development Report. » more
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Search
Search
Advanced Search
Download Center
PDFHighlights
(PDF 196 KB)
Add to Download Center
Services
Order print version
Event Reminder
Press Newsletter
Would you like to be kept informed about new financial reports from Bayer?
SMS Service
Calendar
Spring Financial News Conference
 
Investor Conference Call
 
Annual Stockholders' Meeting 2007
Info
Notes on our information package and all services
zoom - normal view 100% zoom +